Sun, Aug 18 1:08am

Compare DVAX



Dynavax Technologies Corp [DVAX]
$3.99 0.08 (2.05%)

DVAX Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 250 Million
DVAX Description

Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. It's current product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. Dynavax operates in the business segment the discovery and development of biopharmaceutical products. Its Toll-like Receptor Immune Modulation Platform technology play a vital role in innate immunity and subsequent adaptive immunity. Signaling through these receptors is triggered by the binding of a variety of pathogen-associated molecules and is essential to the generation of innate immunity.


Visit Website

DVAX Earnings

EPS -0.62 P/E Ratio 0.00
Previous Earnings Wed, May 8, 2019
Latest Earnings Wed, Aug 7, 2019 (11 days ago) +38.54%

DVAX Dividend

Yield --
Ex-Date --
Pay Date --
History --

DVAX Charts

$2.60
1 Year
$14.20
Jul 30, 2019
Aug 31, 2018



Symbol Price Day % YTD %
DVAX $3.99 2.05% -57.78%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy